SYNTA PHARMACEUTICALS CORP 4
4 · SYNTA PHARMACEUTICALS CORP · Filed Mar 4, 2015
Insider Transaction Report
Form 4
Vukovic Vojo
SVP, Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-03-02+173,280→ 173,280 totalExercise: $2.38Exp: 2025-03-02→ Common Stock (173,280 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the shares on March 2, 2016 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.